<DOC>
	<DOCNO>NCT02198703</DOCNO>
	<brief_summary>This study aim demonstrate effect chronic consumption AB-Life probiotic blend blood LDL cholesterol level volunteer moderate hypercholesterolemia .</brief_summary>
	<brief_title>A Trial Evaluate Efficacy AB-Life Probiotic Product LDL-Cholesterol Reduction Moderate Hypercholesterolemia</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<criteria>To eligible study , male female volunteer fulfill follow criterion ( assessment base medical examination perform V1 check V3 ) : Age 18 65 year ( limit include ) . BMI 18,5 30 kg/m² ( ( limit exclude ) . For woman : Non menopausal reliable contraception since least two cycle begin study agree keep entire duration study ( condom alone without spermicide gel oestrogenic contraceptive exclude ) menopausal without oestrogenic replacement therapy . Good general mental health opinion investigator : clinically significant relevant abnormality medical history physical examination . Able willing participate study comply protocol procedure evidence dated sign informed consent form . Affiliated social security scheme . Agree register volunteer biomedical research file . After V1 biological analysis subject eligible visit V2 follow criterion : Fasting plasma LDLc level ( Friedewald estimation method ) 1,3 1,89 g/L ( 3,35 4,92 mmol/L , limit include ± 2 % tolerate around ) . After V2 biological analysis subject eligible study follow criterion : Fasting plasma LDLc level ( Friedewald estimation method ) 1,3 1,89 g/L ( 3,35 4,92 mmol/L , limit include ± 2 % tolerate around ) . A rescreening occur 2 month exit study failure comply one eligibility criterion list . Volunteers follow criterion consider non eligible study ( assessment base medical examination perform V1 check V3 ) : Suffering metabolic disorder diabetes , uncontrolled thyroidal trouble chronic severe disease . Suffering severe chronic disease ( e.g . cancer , HIV , renal failure , hepatic biliary disorder ongoing , chronic inflammatory digestive disease , arthritis chronic respiratory trouble , etc . ) gastrointestinal disorder find inconsistent conduct study investigator ( e.g . celiac disease ) . With history ischemic cardiovascular event , previous 6 month surgical procedure . With know suspect food allergy intolerance hypersensitivity study product ' ingredient . Suffering uncontrolled hypertension ( systolic blood pressure ≥ 160 mmHg diastolic blood pressure ≥ 100 mmHg ) . Pregnant lactate woman intend become pregnant within 5 month ahead . Under lipidlowering treatment ( e.g . statin , fibrates , ezetimibe , bile acid sequestrants , niacin , etc . ) stop less 4 month randomization . Under medication could affect blood lipid parameter ( e.g . longterm corticosteroid systemic drug , systemic antibody , androgen phenytoin , etc . ) stop less 1 month randomization ( stable longterm treatment beta blocker thiazide diuretic tolerate ) . Regular intake dietary supplement `` functional food '' may interfere lipid absorption and/or metabolism ( e.g . rich plant stanol sterol like PROACTIV DANACOL product , red yeast rice , policosanol , omega3 fatty acid like fish oil , ST HUBERT OMEGA 3 PRIMEVERE product , soya protein , oat fiber like QUAKER OATS , psyllium , chitosan , guar gum , inulin , etc . ) stop less 3 month randomization . Under treatment could disturb microbiota balance stop short period randomization ( e.g . le one month laxatives , less 6 week antibiotic ) . Regular intake dietary supplement `` functional food '' contain prebiotics , probiotic symbiotics ( e.g . BION 3 , LACTIBIANE , ACTIMEL , ACTIVIA , etc . ) stop less 1 month randomization . Under treatment dietary supplement could significantly affect parameter ( ) follow study accord investigator stop short period randomization . With significant change food habit physical activity 3 month randomization agree keep unchanged throughout study . With report body weight variation &gt; 5 % 3 month prior randomization hyper hypocaloric diet plan next 5 month . With personal history anorexia nervosa , bulimia significant eating disorder accord investigator . Consuming 3 standard drink alcoholic beverage daily men 2 standard drink daily woman agree keep alcohol consumption habit unchanged throughout study . Smoking 10 cigarette daily agree keep smoking habit unchanged throughout study . Recent history chronic alcohol drug abuse ( last 2 year ) . Having lifestyle deem incompatible study accord investigator include high level physical activity ( define 10 hour significant physical activity week , walk exclude ) . Who make blood donation 3 month randomization intend make within 4 month ahead . Taking part another clinical trial exclusion period previous clinical trial . Having receive , last 12 month , indemnity clinical trial high equal 4500 Euros . Under legal protection ( guardianship , wardship ) deprive right follow administrative judicial decision . Presenting psychological linguistic incapability sign inform consent . Impossible contact case emergency . After V1 biological analysis subject consider non eligible study follow criterion : Fasting plasma glucose level &gt; 1,26 g/L ( 6,99 mmol/L ) . Fasting plasma triglyceride &gt; 3,5 g/L ( 3,95 mmol/L ) . Fasting plasma TC , HDLc insulin abnormality judge clinically significant accord investigator . After V2 biological analysis subject consider non eligible study follow criterion : Fasting plasma TC , HDL TG abnormality judge clinically significant accord investigator . Serum AST , ALT , GGT , ALP bilirubin abnormality judge clinically significant accord investigator . Serum urea creatinine abnormality judge clinically significant accord investigator . Complete blood count clinically significant abnormality accord investigator . Volunteers follow criterion V3 consider non eligible study : Capsules ' consumption le 80 % capsule runin period ( since V1 ) accord quantity return . Gastroenteritis history finish less 2 week randomization . The included subject randomize V3 short wash period relate non inclusion criterion E8 , E10 , E12 E34 delay visit V3 without exceed 28 day visit V2 . A rescreening occur 2 month exit study failure comply one eligibility criterion list ( except E33 criterion ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Probiotics</keyword>
	<keyword>AB-Life</keyword>
	<keyword>LDL-cholesterol</keyword>
	<keyword>Hypercholesterolemia</keyword>
</DOC>